Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Life Sciences BPO Market

ID: MRFR/LS/8689-HCR
138 Pages
Rahul Gotadki
Last Updated: May 13, 2026

Life Sciences BPO Market Research Report Information By Service Type (Pharmaceutical Outsourcing, [Contract Research Organizations (CROs), {Drug Discovery, Pre-clinical Studies, Clinical Trial Studies, Regulatory Services, Pharmacovigilance}, Contract Manufacturing Organizations (CMOs) {API (Active Pharmaceutical Ingredient), Finished Dose Form, Packaging}, Medical Devices Outsourcing {Contract Manufacturing, Contract Research}, Contract Sales & Marketing Outsourcing {Sales Force Support, Market Access Services, Brand/CRM Support}, Other Service Categories), By End User(Pharmaceutical companies, Biotechnology companies, Medical device companies) - Growth & Industry Forecast 2026 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Service Type (USD Billion)
      1. 4.1.1 Contract Research
      2. 4.1.2 Drug Discovery
      3. 4.1.3 Pre-Clinical Trials
      4. 4.1.4 Clinical Trials
      5. 4.1.5 Medical Writing
      6. 4.1.6 Pharmacovigilance
      7. 4.1.7 Clinical Data Management
      8. 4.1.8 Regulatory Services
      9. 4.1.9 Clinical Monitoring
    2. 4.2 Healthcare, BY Protocol (USD Billion)
      1. 4.2.1 Development
      2. 4.2.2 Site Management
    3. 4.3 Healthcare, BY Region (USD Billion)
      1. 4.3.1 North America
        1. 4.3.1.1 US
        2. 4.3.1.2 Canada
      2. 4.3.2 Europe
        1. 4.3.2.1 Germany
        2. 4.3.2.2 UK
        3. 4.3.2.3 France
        4. 4.3.2.4 Russia
        5. 4.3.2.5 Italy
        6. 4.3.2.6 Spain
        7. 4.3.2.7 Rest of Europe
      3. 4.3.3 APAC
        1. 4.3.3.1 China
        2. 4.3.3.2 India
        3. 4.3.3.3 Japan
        4. 4.3.3.4 South Korea
        5. 4.3.3.5 Malaysia
        6. 4.3.3.6 Thailand
        7. 4.3.3.7 Indonesia
        8. 4.3.3.8 Rest of APAC
      4. 4.3.4 South America
        1. 4.3.4.1 Brazil
        2. 4.3.4.2 Mexico
        3. 4.3.4.3 Argentina
        4. 4.3.4.4 Rest of South America
      5. 4.3.5 MEA
        1. 4.3.5.1 GCC Countries
        2. 4.3.5.2 South Africa
        3. 4.3.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 IQVIA (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Cognizant (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Labcorp Drug Development (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Parexel International (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Charles River Laboratories (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 PRA Health Sciences (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Syneos Health (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Wuxi AppTec (CN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Medpace (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY SERVICE TYPE
    4. 6.4 US MARKET ANALYSIS BY PROTOCOL
    5. 6.5 CANADA MARKET ANALYSIS BY SERVICE TYPE
    6. 6.6 CANADA MARKET ANALYSIS BY PROTOCOL
    7. 6.7 EUROPE MARKET ANALYSIS
    8. 6.8 GERMANY MARKET ANALYSIS BY SERVICE TYPE
    9. 6.9 GERMANY MARKET ANALYSIS BY PROTOCOL
    10. 6.10 UK MARKET ANALYSIS BY SERVICE TYPE
    11. 6.11 UK MARKET ANALYSIS BY PROTOCOL
    12. 6.12 FRANCE MARKET ANALYSIS BY SERVICE TYPE
    13. 6.13 FRANCE MARKET ANALYSIS BY PROTOCOL
    14. 6.14 RUSSIA MARKET ANALYSIS BY SERVICE TYPE
    15. 6.15 RUSSIA MARKET ANALYSIS BY PROTOCOL
    16. 6.16 ITALY MARKET ANALYSIS BY SERVICE TYPE
    17. 6.17 ITALY MARKET ANALYSIS BY PROTOCOL
    18. 6.18 SPAIN MARKET ANALYSIS BY SERVICE TYPE
    19. 6.19 SPAIN MARKET ANALYSIS BY PROTOCOL
    20. 6.20 REST OF EUROPE MARKET ANALYSIS BY SERVICE TYPE
    21. 6.21 REST OF EUROPE MARKET ANALYSIS BY PROTOCOL
    22. 6.22 APAC MARKET ANALYSIS
    23. 6.23 CHINA MARKET ANALYSIS BY SERVICE TYPE
    24. 6.24 CHINA MARKET ANALYSIS BY PROTOCOL
    25. 6.25 INDIA MARKET ANALYSIS BY SERVICE TYPE
    26. 6.26 INDIA MARKET ANALYSIS BY PROTOCOL
    27. 6.27 JAPAN MARKET ANALYSIS BY SERVICE TYPE
    28. 6.28 JAPAN MARKET ANALYSIS BY PROTOCOL
    29. 6.29 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE
    30. 6.30 SOUTH KOREA MARKET ANALYSIS BY PROTOCOL
    31. 6.31 MALAYSIA MARKET ANALYSIS BY SERVICE TYPE
    32. 6.32 MALAYSIA MARKET ANALYSIS BY PROTOCOL
    33. 6.33 THAILAND MARKET ANALYSIS BY SERVICE TYPE
    34. 6.34 THAILAND MARKET ANALYSIS BY PROTOCOL
    35. 6.35 INDONESIA MARKET ANALYSIS BY SERVICE TYPE
    36. 6.36 INDONESIA MARKET ANALYSIS BY PROTOCOL
    37. 6.37 REST OF APAC MARKET ANALYSIS BY SERVICE TYPE
    38. 6.38 REST OF APAC MARKET ANALYSIS BY PROTOCOL
    39. 6.39 SOUTH AMERICA MARKET ANALYSIS
    40. 6.40 BRAZIL MARKET ANALYSIS BY SERVICE TYPE
    41. 6.41 BRAZIL MARKET ANALYSIS BY PROTOCOL
    42. 6.42 MEXICO MARKET ANALYSIS BY SERVICE TYPE
    43. 6.43 MEXICO MARKET ANALYSIS BY PROTOCOL
    44. 6.44 ARGENTINA MARKET ANALYSIS BY SERVICE TYPE
    45. 6.45 ARGENTINA MARKET ANALYSIS BY PROTOCOL
    46. 6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE
    47. 6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROTOCOL
    48. 6.48 MEA MARKET ANALYSIS
    49. 6.49 GCC COUNTRIES MARKET ANALYSIS BY SERVICE TYPE
    50. 6.50 GCC COUNTRIES MARKET ANALYSIS BY PROTOCOL
    51. 6.51 SOUTH AFRICA MARKET ANALYSIS BY SERVICE TYPE
    52. 6.52 SOUTH AFRICA MARKET ANALYSIS BY PROTOCOL
    53. 6.53 REST OF MEA MARKET ANALYSIS BY SERVICE TYPE
    54. 6.54 REST OF MEA MARKET ANALYSIS BY PROTOCOL
    55. 6.55 KEY BUYING CRITERIA OF HEALTHCARE
    56. 6.56 RESEARCH PROCESS OF MRFR
    57. 6.57 DRO ANALYSIS OF HEALTHCARE
    58. 6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    59. 6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    60. 6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
    61. 6.61 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
    62. 6.62 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
    63. 6.63 HEALTHCARE, BY PROTOCOL, 2024 (% SHARE)
    64. 6.64 HEALTHCARE, BY PROTOCOL, 2024 TO 2035 (USD Billion)
    65. 6.65 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY PROTOCOL, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY PROTOCOL, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY PROTOCOL, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY PROTOCOL, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY PROTOCOL, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY PROTOCOL, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY PROTOCOL, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY PROTOCOL, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY PROTOCOL, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY PROTOCOL, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY PROTOCOL, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY PROTOCOL, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY PROTOCOL, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY PROTOCOL, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY PROTOCOL, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY PROTOCOL, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY PROTOCOL, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY PROTOCOL, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY PROTOCOL, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY PROTOCOL, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY PROTOCOL, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY PROTOCOL, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY PROTOCOL, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY PROTOCOL, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY PROTOCOL, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY PROTOCOL, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY PROTOCOL, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY PROTOCOL, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY PROTOCOL, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Service Type (USD Billion, 2025-2035)

  • Contract Research
  • Drug Discovery
  • Pre-Clinical Trials
  • Clinical Trials
  • Medical Writing
  • Pharmacovigilance
  • Clinical Data Management
  • Regulatory Services
  • Clinical Monitoring

Healthcare By Protocol (USD Billion, 2025-2035)

  • Development
  • Site Management

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions